News
Let’s get straight to the gut—literally. If you’ve been riding the rollercoaster of stress eating, stubborn belly fat, and metabolic mayhem, Cannabigerol (CBG) might just be your next secret weapon. Among its growing list of benefits, CBG is earning a spotlight for its role in controlling weight, reducing fat storage, and supporting a healthier, leaner body—without the sketchy side effects of crash diets or stimulants.
Recent research highlights the potential of non-psychoactive cannabinoids—CBD, CBG, and CBN—as promising therapeutic tools for Autism Spectrum Disorder (ASD). CBD has shown efficacy in reducing anxiety, aggression, and sleep disturbances, while CBG may support cognitive function and reduce neuroinflammation. CBN, often associated with sleep improvement, is also being studied for its neurogenic properties. The most significant benefits appear when these compounds work together in full-spectrum formulations, leveraging the entourage effect to enhance symptom relief. While further large-scale studies are needed, these findings suggest that cannabinoids could play a transformative role in ASD treatment.
